Skip to content
DataLookout
Menu

NCT05756699

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Notable Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v4
  3. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2023 to Apr 10, 2023
    • Collaborator revised
    v3
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

HCC detection rate
Timeframe: Up to 2 years

Secondary (3)

Early HCC detection rate
False referral rate
Positive predictive value

Arms and interventions

Diagnostic tests: multiple reaction monitoring (MRM)-based multimarker panel

Sites

1 site in 1 country

  • Seoul National University HospitalSeoul, South Korea